North America Farm Animal Drugs Market Growth Opportunities and Forecast by 2028
Historic Data: 2019-2020 | Base Year: 2021 | Forecast Period: 2022-2028North America Farm Animal Drugs Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Anti-Infective, Parasiticides, Anti-inflammatory, Anesthetics, Analgesics, Hormones and Related Product, and Others), Animal Type (Livestock Animal, and Equine), Route of Administration (Oral, Parenteral, Topical, and Others), Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies and Drug Stores, and Others)
- Report Date : Jan 2022
- Report Code : TIPRE00026655
- Category : Life Sciences
- Status : Published
- Available Report Formats :
- No. of Pages : 175
The North America farm animal drugs market is expected to reach US$ 12,454.7 million by 2028 from US$ 7,848.8 million in 2021. The market is estimated to grow at a CAGR of 6.8% from 2021–2028.
Consumers are becoming increasingly aware and concerned about the welfare of animals raised for food. This has put pressure on suppliers to ensure that animals entering their systems are treated humanely. Measures are being taken for addressing such demand. Only one drug is approved in the US to control interdigital phlegmon (foot rot) pain in non-lactating cattle. Therefore, using medications for pain management in elective procedures, such as dehorning and castration, in cattle or analgesia in lactating dairy cows and pigs is considered an extra-label drug use. It is regulated as per the clarification on the use of veterinary drugs law. Flunixin, meloxicam, and ketoprofen are nonsteroidal anti-inflammatory drugs with supportive research on on-farm analgesia. Several products, such as local and regional anesthetics, opioids, and nonsteroidal anti-inflammatory drugs (NSAIDs), are available in the market to relieve pain in animals. Thus, such advancements are accelerating growth of the North America farm animal drugs marketSome associations, such as the Canadian Cattlemen's Association, has called farmers to put cattle on maintenance rations rather than finishing rations to limit feedlot placements, coping with the closure of processing plants, and limited market capacities. Indeed, many farmers failed to obtain essential veterinary services, including routine health check-ins, drugs, vaccines, and testing and diagnostic tools. Thus, disease control of animals has become an additional challenge conflicting with animal welfare aspects. Unfortunately, the effect of COVID-19 on the activities related to animal healthcare is not restricted only on the farm-scale, but there are also national and international restrictions. The pandemic's impact on the livestock supply chain affected the local marketing process by reducing marketing opportunities, blocking of import/export activity, and lowering purchasing power, and consumers', demand (misconception regarding animal products safety and reduced consumers' income). All of these interruptions in the livestock supply chain put the producers (farmers) at risk of not being able to continue in the field. The limitation of movements and the disruption of national and international trade routes drive to a substantial decrease in vital livestock farming materials and facilities, such as feed materials, replacement stocks (e.g., day-old chicks, piglets, gilts, heifers, and semen straws), drugs and vaccines, feed additives, and other livestock farming inputs. Thus, Covid-19 has a negative impact on the market’s growth.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the farm animal drugs market. The North America farm animal drugs market is expected to grow at a good CAGR during the forecast period.
North America Farm animal drugs Market Revenue and Forecast to 2028 (US$ Million)
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
North America Farm Animal Drugs Market Segmentation
By Product Type
- Anti-Infective
- Parasiticides
- Anti-inflammatory
- Anesthetics
- Analgesics
- Hormones and Related Products
- Others
By Animal Type
- Livestock Animal
- Equine
By Route of Administration
- Oral
- Parenteral
- Topical
- Others
By Distribution Channel
- Veterinary Hospitals
- Veterinary Clinics
- Pharmacies and Drug Stores
- Others
By Country
- North America
- US
- Canada
- Mexico
Companies Mentioned
- PHIBRO ANIMAL HEALTH CORPORATION
- Zoetis Inc.
- Ceva
- Elanco
- Virbac
- INTAS PHARMACEUTICALS LTD.
- Alembic Pharmaceuticals Limited
- Boehringer Ingelheim International GmbH
- MSD Animal Health
North America Farm Animal Drugs Report Scope
Report Attribute
Details
Market size in 2021
US$ 7,848.8 Million
Market Size by 2028
US$ 12,454.7 Million
Global CAGR (2021 - 2028)
6.8%
Historical Data
2019-2020
Forecast period
2022-2028
Segments Covered
By Product Type - Anti-Infective
- Parasiticides
- Anti-inflammatory
- Anesthetics
- Analgesics
- Hormones and Related Product
By Animal Type - Livestock Animal
- Equine
By Route of Administration - Oral
- Parenteral
- Topical
By Distribution Channel - Veterinary Hospitals
- Veterinary Clinics
- Pharmacies and Drug Stores
Regions and Countries Covered
North America - US
- Canada
- Mexico
Market leaders and key company profiles
PHIBRO ANIMAL HEALTH CORPORATION
Zoetis Inc.
Ceva
Elanco
Virbac
INTAS PHARMACEUTICALS LTD.
Alembic Pharmaceuticals Limited
Boehringer Ingelheim International GmbH
MSD Animal Health
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 7,848.8 Million |
| Market Size by 2028 | US$ 12,454.7 Million |
| Global CAGR (2021 - 2028) | 6.8% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Product Type
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Recent Reports
Testimonials
I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.
The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
YUKIHIKO ADACHI CEO, Deep Blue, LLC.
We worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.
PIYUSH NAGPAL Sr. Vice President, High Beam Global
I requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.
Jean-Herve Jenn Chairman, Future Analytica
This is the first time I have purchased a market report from The Insight Partners.While I was unsure at first, I visited their web site and felt more comfortable to take the risk and purchase a market report.I am completely satisfied with the quality of the report and customer service. I had several questions and comments with the initial report, but after a couple of dialogs over email with their analyst I believe I have a report that I can use as input to our strategic planning process.Thank you so much for taking the extra time and making this a positive experience.I will definitely recommend your service to others and you will be my first call when we need further market data.
John Suzuki President and Chief Executive Officer, Board Director, BK TechnologiesReason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.
- PHIBRO ANIMAL HEALTH CORPORATION
- Zoetis Inc.
- Ceva
- Elanco
- Virbac
- INTAS PHARMACEUTICALS LTD.
- Alembic Pharmaceuticals Limited
- Boehringer Ingelheim International GmbH
- MSD Animal Health
Get Free Sample For